Bookmark and Share

Ex-Dividend Date Reminder For Next Week February 13-19, 2012

Here is a current overview of best yielding stocks that have their ex-dividend date on the next trading day. If your broker settles your trade today, you will receive the next dividend. A full list of all stocks with ex-dividend date can be found here: Ex-Dividend Stocks February 13-19, 2012. In total, 204 stocks and preferred shares go ex-dividend of which 95 yielding above 3 percent. The average yield amounts to 4.02 percent.

The ex-dividend date is a major date related to the payment of dividends. If you purchase a stock on its ex-dividend date or later, you will not receive the next dividend payment. Instead, the seller gets the dividend. If you purchase before the ex-dividend date, you get the dividend. It is important that your broker settles your trade before the ex-dividend date.

These are the results of the best yielding large cap stocks:

Southern Copper Corp. (SCCO) has a market capitalization of USD 28.33 Billion and operates within the “Copper” industry. These are the market ratios of the company:


P/E Ratio: 12.48,
Forward P/E Ratio: 13.21,
Price/Sales Ratio: 4.26,
Price/Book Ratio: 6.90,
Dividend Yield: 6.14%.


Long-Term Stock History Chart Of Southern Copper Corp. (Click to enlarge)
Long-Term Dividend History of Southern Copper Corp. (SCCO) (Click to enlarge)
Long-Term Dividend Yield History of Southern Copper Corp. (SCCO) (Click to enlarge)


AstraZeneca PLC (AZN) has a market capitalization of USD 60.48 Billion and operates within the “Drug Manufacturers - Major” industry. These are the market ratios of the company:


P/E Ratio: 6.47,
Forward P/E Ratio: 7.78,
Price/Sales Ratio: 1.80,
Price/Book Ratio: 2.62,
Dividend Yield: 5.73%.


Long-Term Stock History Chart Of AstraZeneca PLC (Click to enlarge)
Long-Term Dividend History of AstraZeneca PLC (AZN) (Click to enlarge)
Long-Term Dividend Yield History of AstraZeneca PLC (AZN) (Click to enlarge)


Exelon Corporation (EXC) has a market capitalization of USD 26.41 Billion and operates within the “Diversified Utilities” industry. These are the market ratios of the company:


P/E Ratio: 10.62,
Forward P/E Ratio: 14.13,
Price/Sales Ratio: 1.38,
Price/Book Ratio: 1.84,
Dividend Yield: 5.27%.


Long-Term Stock History Chart Of Exelon Corporation (Click to enlarge)
Long-Term Dividend History of Exelon Corporation (EXC) (Click to enlarge)
Long-Term Dividend Yield History of Exelon Corporation (EXC) (Click to enlarge)


Eli Lilly & Co. (LLY) has a market capitalization of USD 45.51 Billion and operates within the “Drug Manufacturers - Major” industry. These are the market ratios of the company:


P/E Ratio: 10.08,
Forward P/E Ratio: 10.77,
Price/Sales Ratio: 1.87,
Price/Book Ratio: 2.91,
Dividend Yield: 4.99%.


Long-Term Stock History Chart Of Eli Lilly & Co. (Click to enlarge)
Long-Term Dividend History of Eli Lilly & Co. (LLY) (Click to enlarge)
Long-Term Dividend Yield History of Eli Lilly & Co. (LLY) (Click to enlarge)


GlaxoSmithKline plc (GSK) has a market capitalization of USD 113.03 Billion and operates within the “Drug Manufacturers - Major” industry. These are the market ratios of the company:


P/E Ratio: 21.83,
Forward P/E Ratio: 13.05,
Price/Sales Ratio: 2.59,
Price/Book Ratio: 9.46,
Dividend Yield: 4.93%.


Long-Term Stock History Chart Of GlaxoSmithKline plc (Click to enlarge)
Long-Term Dividend History of GlaxoSmithKline plc (GSK) (Click to enlarge)
Long-Term Dividend Yield History of GlaxoSmithKline plc (GSK) (Click to enlarge)


Thomson Reuters Corporation (TRI) has a market capitalization of USD 21.96 Billion and operates within the “Information & Delivery Services” industry. These are the market ratios of the company:


P/E Ratio: 15.89,
Forward P/E Ratio: 11.90,
Price/Sales Ratio: 1.60,
Price/Book Ratio: 1.13,
Dividend Yield: 4.67%.


Long-Term Stock History Chart Of Thomson Reuters Corporation (Click to enlarge)
Long-Term Dividend History of Thomson Reuters Corporation (TRI) (Click to enlarge)
Long-Term Dividend Yield History of Thomson Reuters Corporation (TRI) (Click to enlarge)

No comments:

Post a Comment

Do you have any questions or notes to this article?
Please let me know your thoughts and we will discuss it.